<VariationArchive VariationID="431049" VariationName="NM_006345.4(SLC30A9):c.1049_1051del (p.Ala350del)" VariationType="Deletion" Accession="VCV000431049" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-10" DateCreated="2017-08-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="424578" VariationID="431049">
      <GeneList>
        <Gene Symbol="SLC30A9" FullName="solute carrier family 30 member 9" GeneID="10463" HGNC_ID="HGNC:1329" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="41990530" stop="42090461" display_start="41990530" display_stop="42090461" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="41992522" stop="42089550" display_start="41992522" display_stop="42089550" Strand="+" />
          </Location>
          <OMIM>604604</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006345.4(SLC30A9):c.1049_1051del (p.Ala350del)</Name>
      <CanonicalSPDI>NC_000004.12:42065323:AGCAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="42065324" stop="42065326" display_start="42065324" display_stop="42065326" variantLength="3" positionVCF="42065323" referenceAlleleVCF="TAGC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="42067341" stop="42067343" display_start="42067341" display_stop="42067343" variantLength="3" positionVCF="42067340" referenceAlleleVCF="TAGC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A350del</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006345.3" sequenceAccession="NM_006345" sequenceVersion="3" change="c.1047_1049delGCA">
            <Expression>NM_006345.3:c.1047_1049delGCA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.42067343_42067345del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.42067343_42067345del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.42065326_42065328del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.42065326_42065328del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006345.4" sequenceAccession="NM_006345" sequenceVersion="4" change="c.1049_1051del" MANESelect="true">
            <Expression>NM_006345.4:c.1049_1051del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006336.3" sequenceAccession="NP_006336" sequenceVersion="3" change="p.Ala350del">
            <Expression>NP_006336.3:p.Ala350del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006345.4" sequenceAccession="NM_006345" sequenceVersion="4" change="c.1049_1051delCAG" MANESelect="true">
            <Expression>NM_006345.4:c.1049_1051delCAG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645372394" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604604.0001" DB="OMIM" />
        <XRef Type="rs" ID="1131692331" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff established the standard HGVS expression for the deletion based on review of the sequence in Figure 2 of the paper by Perez et al., 2017 (PubMed 28334855).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006345.4(SLC30A9):c.1049_1051del (p.Ala350del) AND Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome" Accession="RCV000496089" Version="5">
        <ClassifiedConditionList TraitSetID="36938">
          <ClassifiedCondition DB="MedGen" ID="C4539828">Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-08-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28334855</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28638141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34433664</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="36938" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="37952" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Birk-Landau-Perez syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome</ElementValue>
                <XRef ID="MONDO:0044726" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BILAPES</ElementValue>
                <XRef Type="MIM" ID="617595" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17943" />
                <XRef ID="17943" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="505242" DB="Orphanet" />
              <XRef ID="C4539828" DB="MedGen" />
              <XRef ID="MONDO:0044726" DB="MONDO" />
              <XRef Type="MIM" ID="617595" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7335930" SubmissionDate="2023-05-16" DateLastUpdated="2023-05-20" DateCreated="2023-05-13">
        <ClinVarSubmissionID localKey="SUB13304314" submittedAssembly="GRCh37" title="SUB13304314" />
        <ClinVarAccession Accession="SCV003923319" DateUpdated="2023-05-20" DateCreated="2023-05-13" Type="SCV" Version="2" SubmitterName="UAEU Genomics Laboratory, United Arab Emirates University" OrgID="509098" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">28334855</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">34433664</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">28638141</ID>
          </Citation>
          <Comment>The in-frame deletion NM_006345.4(SLC30A9):c.1049_1051delCAG (p.Ala350del) has been reported previously in 6 individuals from a Bedouin kindred affected with Birk-Landau-Perez syndrome (Perez et al., 2017). This variant is not present in gnomAD database (Karczewski et al., 2020) and Middle Eastern specific databases (Koshy et al., 2017). The removed amino acid is highly conserved and is located at the predicted cation-efflux domain of the mature SLC30A9 protein. In vitro functional studies in human neuroblastoma cells showed a significant decrease in cytosolic free Zn2+ levels in cells expressing the mutant compared to the wild type. (Perez et al., 2017).Further, in CRISPR-Cas9 knockout (SLC30A9 -/-) cell lines, functional complementation of the p.Ala350Del variant failed to restore the functional defect caused by genetic ablation of SLC30A9, indicating that the p.Ala350Del variant is a loss-of-function allele (Deng et al., 2021). Aggregating all the available evidence (PM2, PM1, PS3, PP1_strong), this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC30A9">
              <Name>solute carrier family 30 member 9</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006345.4:exon 12</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006345.4:c.1049_1051delCAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617595" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13304314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1139455" SubmissionDate="2017-08-08" DateLastUpdated="2024-06-09" DateCreated="2017-07-31">
        <ClinVarSubmissionID localKey="604604.0001_BIRK-LANDAU-PEREZ SYNDROME" title="SLC30A9, 3-BP DEL, 1047GCA_BIRK-LANDAU-PEREZ SYNDROME" />
        <ClinVarAccession Accession="SCV000584195" DateUpdated="2024-06-09" DateCreated="2017-07-31" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 6 affected individuals from a highly consanguineous Bedouin kindred from Saudi Arabia with Birk-Landau-Perez syndrome (BILAPES; 617595), Perez et al. (2017) identified a homozygous in-frame 3-bp deletion (c.1047_1049delGCA, NM_006345.3) in the SLC30A9 gene, resulting in the deletion of a conserved residue (Ala350del) within the cation efflux domain. The mutation, which was found by a combination of homozygosity mapping and whole-exome sequencing, was confirmed by Sanger sequencing. It segregated with the disorder in the family and was not found in the dbSNP, 1000 Genomes Project, Exome Sequencing Project, or ExAC databases. The variant was found once in heterozygous state in 1 of 600 control Bedouin chromosomes. Molecular modeling indicated that Ala350del was in the fourth helix transmembrane domain, predicted to result in protein destabilization and defective function. In vitro functional expression assays in human neuroblastoma cells showed that, compared to wildtype, the mutant protein localized similarly, but caused a significant decrease in cytosolic free zinc levels. The findings were consistent with a defect in zinc homeostasis, which would likely have an effect on various cellular functions.</Attribute>
              <Citation>
                <ID Source="PubMed">28334855</ID>
              </Citation>
              <XRef DB="OMIM" ID="617595" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC30A9" />
          </GeneList>
          <Name>SLC30A9, 3-BP DEL, 1047GCA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 1047GCA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604604.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BIRK-LANDAU-PEREZ SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1139455" TraitType="Disease" MappingType="Name" MappingValue="BIRK-LANDAU-PEREZ SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C4539828" Name="Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7335930" TraitType="Disease" MappingType="XRef" MappingValue="617595" MappingRef="OMIM">
        <MedGen CUI="C4539828" Name="Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

